A novel prognostic model to predict mortality in patients with acute-chronic liver failure in intensive care unit

Author:

Lin Shih-Hua1,Chen Wei-Ting1,Tsai Ming-Hung1,Liu Li-Tong1,Kuo Wei-Liang1,Lin Yan-Ting1,Wang Sheng-Fu1,Chen Bo-Huan1,Lee Cheng-Han1,Huang Chien-Hao2ORCID,Chien Rong-Nan1

Affiliation:

1. Linkou Chang Gung Memorial Hospital: Chang Gung Memorial Hospital Linkou

2. Chang Gung Memorial Hospital Linkou

Abstract

Abstract Background Acute on chronic liver failure (ACLF) implies high short-term mortality rates and usually requires intensive care unit (ICU) admission. Proper prognosing these patients is crucial for early referral for liver transplantation. The superiority of CLIF-C ACLF score in Asian patients with ACLF admitted to an ICU remains inconclusive when compared to other scoring systems. The purpose of the study is (i) to compare the predictive performance of original MELD, MELD-Lactate, CLIF-C ACLF, CLIF-C ACLF-Lactate, and APACHE-II scores for short-term mortality assessment. (ii) to build and validate a novel scoring system and to compare its predictive performance to that of the original five scores. Methods 265 consecutive cirrhotic patients with ACLF who were admitted to our ICU were enrolled. The prognostic values for mortality were assessed by ROC analysis. A novel model was developed and internally validated using 5-fold cross-validation. Results Alcohol abuse was identified as the primary etiology of cirrhosis. The AUROC of the five prognostic scores in predicting one-month mortality prediction were not significantly superior to each other in predicting one-month and three-month mortality. The newly developed prognostic model, incorporating age, A-a gradient, BUN, total bilirubin level, INR, and HE grades, exhibited significantly improved performance in predicting one-month and three-month mortality with AUROC of 0.863 and 0.829, respectively, as compared to the original five prognostic scores. Conclusions The novel ACLF model is superior to the original five scores in predicting short-term mortality for ACLF patients admitted to an ICU. Further rigorous validation is required.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3